Order Form
“Anytime you get something on the table that generates cost-savings, people perk up”
Public drug plan representative
“Patients want drug access—effective medicines to Canadians in a timely manner. The role of SEBs will be to provide Canadian patients a range of drugs at a range of ... Read More
20
Mar2014
20
Mar2014
Order Form
This special report (25 pages) provides an overview of the Canadian pharmaceutical pricing and reimbursement environment. It includes descriptions of the health care system and pharmaceutical market, and then discusses pharmaceutical pricing including the Patented ... Read More
20
Mar2014
2002 Update Now Available
Download the full 2002 report
Under a fully funded, publicly administered, national pharmacare program, government spending on prescribed drugs could increase by as much as $8.1 billion and would result in a dramatic shift in funding from the private sector to the public sector. The study, ... Read More
20
Mar2014
Abstract
OBJECTIVE. This paper compares the prices of top selling generic drugs in Canada with prices for comparable generic products in the United States.
METHODS. We examined the prices of 27 top selling (in 2001) generic prescription medicines in Canada that were marketed in both Canada and the United States. The sample ... Read More
20
Mar2014
Download the full report (66 Kb): Canada's Pharmaceutical Balance of Trade (PDF)
The purpose of this study is to develop an economic analysis of the Canadian balance of trade in pharmaceuticals. The study presents historical trends in pharmaceutical trade, makes comparisons with other high technology sectors, and outlines opportunities and ... Read More
20
Mar2014
Download the full report (100 Kb): C-91: Background Study on Drug Costs and Benefits (PDF)
This study examines the costs and benefits of pharmaceuticals in relation to the C-91 amendments to the Patent Act. The report is divided into two volumes. Volume 1 presents an analysis of the costs and ... Read More
18
Feb2014
Statistic Canada has released the final Consumer Price Index (CPI) figure for 2013 with full year annual inflation as measured by CPI increasing by 0.9% over 2012. For PMPRB price compliance, this is important for two reasons. First, this is the second year running ... Read More
18
Feb2014
Yesterday marked the beginning of the second phase of the provincial government’s generic drug pricing policy in Newfoundland and Labrador. Generic drugs will now be priced at no more than 40% of the brand price. The province has also now finalized an agreement with the Pharmacists’ Association of Newfoundland and ... Read More
18
Feb2014
Prince Edward Island Premier Robert Ghiz announced a new drug coverage program in a press release today. Designed to “protect individuals and families whose drug costs are consuming an unreasonable share of their income”, the Catastrophic Drug Plan formulary will include approximately 60 drugs and be managed by an expert ... Read More
18
Feb2014
The final phase of Nova Scotia’s Fair Drug Pricing, bringing the price the province pays for generic drugs down to 35 per cent of the relevant brand price, goes into effect in the province today. This is the last of the three-step phase-in of the policy that began in July ... Read More